24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Tourette Syndrome
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:53
Binance is back online after a record crypto theft. The questions are far from settled
20:53
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
20:25
"Security teams are struggling to handle this AI threat"
20:24
"To build a company in Israel for the last four years is not an easy mission"
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Cyber startup Cyera eyes $20 billion valuation in new funding talks
3
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
4
Israeli startup Coldi is deploying AI agents to take over the cold call
5
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
More news
Tourette Syndrome
2 stories about Tourette Syndrome
Teva reaches its highest level since 2017 as investors embrace its transformation
23.08.26
|
CTech
Shares have risen about 20% in August, lifting the Israeli drugmaker's market value to $43.5 billion as innovative medicines and a growing pipeline reshape its investment story.
An Israeli Company Wants to Treat Tourette Syndrome With Cannabis
09.04.18
|
Lilach Baumer
Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday